Current Report · Items 5.03, 7.01, 9.01 · 8-K
FF EAI Robotics Ecosystem Inc.
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 29, 2026, AIxCrypto Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to change the Company’s corporate name from “AIxCrypto Holding…
Filed Sep 29, 2026Accepted Sep 29, 2026, 5:30 PM EDTCIK 1460702Accession 0001493152-26-044923
Company context
We are an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. Our business now consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS).
Current securities
Historical securities (1)
Registered securities in this filing
FF EAI Robotics Ecosystem Inc. · 8-K · Filed 2026-09-29
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.001
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Historical · closed Sep 29, 2026
Filing context
Context: AsOf2026-09-29
Dimensions: Not supplied
Accession 000149315226044923 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 5.03, 7.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.03Item 5.03 - Amendments to Articles/Bylaws
Item
5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
September 29, 2026, AIxCrypto Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of
Amendment”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware
to change the Company’s corporate name from “AIxCrypto Holdings, Inc.” to “FF EAI Robotics Ecosystem Inc.”
(the “Name Change”). The Certificate of Amendment will become effective at 12:01 a.m. Eastern Time on September 30, 2026.
The Certificate of Amendment amends and restates Article I in its entirety to reflect the new name.
Pursuant to a unanimous written consent dated September
23, 2026, the Company’s board of directors approved the Certificate of Amendment in accordance with Section 242 of the Delaware
General Corporation Law (the “DGCL”). Pursuant to Section 242(d)(1)(A) of the DGCL, no meeting or vote of the Company’s
stockholders was required to adopt the Certificate of Amendment.
Also by unanimous
written consent dated September 23, 2026, the Board adopted an amendment (the “Bylaws Amendment”) to the Company’s
Amended and Restated Bylaws, as of August 10, 2021 (the “Bylaws”), to reflect the Name Change. The Bylaws Amendment replaces
each reference in the Bylaws to “Qualigen Therapeutics, Inc.” or “AIxCrypto Holdings, Inc.” with “FF EAI
Robotics Ecosystem Inc.” The Bylaws Amendment will become effective automatically concurrently with the effectiveness of the Certificate
of Amendment at 12:01 a.m. Eastern Time on September 30, 2026. No other changes were made to the Bylaws.
In
connection with the Name Change, the trading symbol for the Company’s common stock on The Nasdaq Capital Market will change from
“AIXC” to “FFR,” effective at market open on September 30, 2026.
The foregoing descriptions
of the Certificate of Amendment and the Bylaws Amendment do not purport to be complete and
are qualified in their entirety by reference to
the full text of the Certificate of Amendment and the Bylaws Amendment, copies of which are
filed as Exhibits 3.1 and 3.2, respectively, to
this Current Report on Form 8-K and incorporated herein by reference.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01. Regulation FD Disclosure.
On
September 29, 2026, the Company presented an investor presentation (the “Investor Presentation”) relating to, among other
things, the Company’s business and strategy, its transition to robotics operations, and the proposed acquisition of the robotics
business of Faraday Future Intelligent Electric Inc. (“FFAI”), the Company’s majority stockholder. A copy of the Investor
Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The Investor Presentation
includes projections prepared by FFAI management for the robotics business on a standalone basis; the Company has not independently verified
or adopted such projections as guidance.
The
information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a filing. The furnishing of this information shall not be deemed
an admission as to the materiality of any information herein that is required to be disclosed solely by Regulation FD.
Filed exhibits (1)